Sarepta Therapeutics (SRPT) Net Cash Flow Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 89.97% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -13.44% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 33.37% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -29.82% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 32.17% |
| 10 | Sarepta Therapeutics | 1.86 Bn | 1.17 Bn | 291.52 Mn | -52.43% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -52.43% |
| Dec 31, 2025 | 66.55% |
| Sep 30, 2025 | -16.30% |
| Jun 30, 2025 | 40.22% |
| Mar 31, 2025 | 0.76% |
| Dec 31, 2024 | 20.50% |
| Sep 30, 2024 | -23.69% |
| Jun 30, 2024 | -30.11% |
| Mar 31, 2024 | 62.02% |
| Dec 31, 2023 | -82.78% |
| Sep 30, 2023 | -23.30% |
| Jun 30, 2023 | 45.84% |
| Mar 31, 2023 | -28.11% |
| Dec 31, 2022 | -38.41% |
| Sep 30, 2022 | 59.26% |
| Jun 30, 2022 | -86.38% |
| Mar 31, 2022 | -63.94% |
| Dec 31, 2021 | 47.53% |
| Sep 30, 2021 | 21.21% |
| Jun 30, 2021 | 51.33% |
| Mar 31, 2021 | 21.15% |
| Dec 31, 2020 | 53.11% |
| Sep 30, 2020 | -33.29% |
| Jun 30, 2020 | -5.31% |
| Mar 31, 2020 | 82.72% |
| Dec 31, 2019 | 33.97% |
| Sep 30, 2019 | -31.91% |
| Jun 30, 2019 | 2.57% |
| Mar 31, 2019 | 120.12% |
| Dec 31, 2018 | 87.39% |
| Sep 30, 2018 | -144.56% |
| Jun 30, 2018 | -210.76% |
| Mar 31, 2018 | -268.34% |
| Dec 31, 2017 | -41.68% |
| Sep 30, 2017 | 121.75% |
| Jun 30, 2017 | -58.51% |
| Mar 31, 2017 | 39.81% |
| Dec 31, 2016 | -153.81% |
| Sep 30, 2016 | 34.11% |
| Jun 30, 2016 | 102.40% |
| Mar 31, 2016 | -28.92% |
| Dec 31, 2015 | -45.31% |
| Sep 30, 2015 | -44.49% |
| Jun 30, 2015 | 6.96% |
| Mar 31, 2015 | 27.95% |
| Dec 31, 2014 | 74.28% |
| Sep 30, 2014 | -86.07% |
| Jun 30, 2014 | 20.19% |
| Mar 31, 2014 | -172.21% |
| Dec 31, 2013 | -91.42% |
| Sep 30, 2013 | 435.50% |